The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Protagonist Therapeutics Inc shares valued at $217,000 were sold by Waddill William D. on Mar 17 ’25. At $54.25 per share, Waddill William D. sold 4,000 shares. The insider’s holdings dropped to 13,130 shares worth approximately $0.7 million following the completion of this transaction.
Also, WILLIAM D WADDILL purchased 4,000 shares, netting a total of over 219,120 in proceeds.
Before that, MOLINA ARTURO MD had sold 30,514 shares from its account. In a trade valued at $1,700,850, the Chief Medical Officer traded Protagonist Therapeutics Inc shares for $55.74 each. Upon closing the transaction, the insider’s holdings decreased to 30,514 shares, worth approximately $4.45 million.
As published in their initiating research note from Goldman on December 06, 2024, Protagonist Therapeutics Inc [PTGX] has been a Neutral and the price target has been revised to $47. Analysts at BMO Capital Markets started covering the stock with ‘”an Outperform”‘ outlook in a report released in early December. As of November 05, 2024, Wedbush has initiated its “an Outperform” rating for PTGX. Earlier on September 24, 2024, TD Cowen initiated its rating. Their recommendation was “a Buy” for PTGX stock.
Analyzing PTGX Stock Performance
During the last five days, there has been a drop of approximately -3.37%. Over the course of the year, Protagonist Therapeutics Inc shares have jumped approximately 37.44%. Shares of the company reached a 52-week high of $60.60 on 03/12/25 and a 52-week low of $33.70 on 02/25/25. A 50-day SMA is recorded $40.90, while a 200-day SMA reached $40.80.
Support And Resistance Levels for Protagonist Therapeutics Inc (PTGX)
According to the 24-hour chart, there is a support level at 52.31, which, if violated, would cause prices to drop to 51.57. In the upper region, resistance lies at 53.95. The next price resistance is at 54.85. RSI (Relative Strength Index) is 64.68 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 4.62, which suggests the price will increase in the coming days. Percent R is at 32.26%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
